Engineered antibodies to combat viral threats
Engineered antibodies to combat viral threats
As the COVID-19 pandemic rages globally, interest in antiviral treatments has never been higher. Antibodies are key defence components, and engineering them to better exploit their natural functions might boost therapeutic options.
398-399
Cragg, Mark
ec97f80e-f3c8-49b7-a960-20dff648b78c
Yu, Xiaojie
44d52374-eacc-4e23-b7da-c881e6d3a5dd
Cragg, Mark
ec97f80e-f3c8-49b7-a960-20dff648b78c
Yu, Xiaojie
44d52374-eacc-4e23-b7da-c881e6d3a5dd
Abstract
As the COVID-19 pandemic rages globally, interest in antiviral treatments has never been higher. Antibodies are key defence components, and engineering them to better exploit their natural functions might boost therapeutic options.
Text
FridayProof_BenandMark
- Accepted Manuscript
More information
e-pub ahead of print date: 18 November 2020
Identifiers
Local EPrints ID: 445956
URI: http://eprints.soton.ac.uk/id/eprint/445956
ISSN: 0028-0836
PURE UUID: 8ef4226e-cb05-411e-8cb4-80d76371a49e
Catalogue record
Date deposited: 15 Jan 2021 17:31
Last modified: 17 Mar 2024 06:12
Export record
Altmetrics
Contributors
Author:
Xiaojie Yu
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics